Flavia Rioja-Torres
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Flavia Rioja-Torres has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Diego Chambergo-Michilot
Universidad Científica del Sur, Lima, Perú
2 shared publications - Akram Hernández-Vásquez
Centro de Excelencia en Investigaciones Económicas y Sociales en Salud, Vicerrectorado de Investigación, Universidad San Ignacio de Loyola, Lima 15024, Peru
1 shared publication - Alfredo Huamán Modesto
Universidad Científica del Sur, Lima, Perú
1 shared publication - Carlos Rodriguez Malaver
Departamento de Emergencia, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru
1 shared publication - Christian Rojas-Contreras
Department of Infectious Diseases, Hospital Nacional Edgardo Rebagliati Martins, Lima, PERU
1 shared publication - Cristina Quiroz-Narvaez
Universidad Científica del Sur, Lima, Perú
1 shared publication
Latest Publications
- 8 November 2025
- Published by Elsevier in Journal of Surgical Research
- Vol. 315, 1047-1049
Response Regarding: Intestinal Volvulus and Geographic Altitude: Nationwide Analysis of Hospitalizations in Peru
- 8 November 2025
- Published by Elsevier in Journal of Surgical Research
- Vol. 315, 1047-1049
Response Regarding: Intestinal Volvulus and Geographic Altitude: Nationwide Analysis of Hospitalizations in Peru
- Open Access
- 18 February 2025
- Published by Universidad Cientifica del Sur
Diferencias sociodemográficas y clínicas según la altitud sobre el nivel del mar en pacientes con vólvulo de sigmoide sometidos a cirugía
Objetivo: Comparar las diferencias sociodemográficas en pacientes que viven en altitudes bajas y altas, diagnosticados con vólvulo de sigmoides y sometidos a intervención quirúrgica entre 2010 y 2022. Métodos: Se realizó un estudio de cohorte retrospectivo que incluyó pacientes sometidos a cirugía por vólvulo de sigmoides entre 2010 y 2022. La población se dividió según la altitud sobre el nivel del mar en la que residían. Se emplearon estadísticas descriptivas y análisis univariado para comparar ambas cohortes. Resultados: El 52,1 % de los pacientes que vivían por debajo de los 2500 metros sobre el nivel del mar (msnm) tenían más de 60 años (55,0 % vs. 52,1 %; p=0,004). La población que vivía por encima de los 2500 msnm presentó un mayor porcentaje de tejido necrótico (70,0 % vs. 31,0 %, p<0,001). No se observaron diferencias en los tipos de cirugía (resección primaria con anastomosis vs. procedimiento de Hartmann; 46,7 % vs. 60,6 %, p=0,112). Los pacientes de altitudes bajas tuvieron más complicaciones totales (18,3 % vs. 36,6 %, p=0,021) y de heridas (10,0 % vs. 26,8 %, p=0,015), a pesar de la mayor frecuencia de tejido necrótico en el grupo de mayor altitud (70,0 % vs. 31,0 %, p<0,001). La mayoría de los pacientes de ambas zonas lograron recuperación completa tras la cirugía (88,3 % vs. 100 %, p=0,003) y fueron dados de alta tras un promedio de 9 días (10,16 vs. 4,85, p=0,160). Conclusiones: Los pacientes con diagnóstico de vólvulo de sigmoides que vivían a más de 2500 metros eran mayores, residían en áreas rurales, presentaban mayor progresión de la enfermedad debido a tejido necrótico, y tenían una menor tasa de complicaciones generales y de heridas...
- 18 February 2025
- Published by Universidad Cientifica del Sur
Open AccessDiferencias sociodemográficas y clínicas según la altitud sobre el nivel del mar en pacientes con vólvulo de sigmoide sometidos a cirugía
Objetivo: Comparar las diferencias sociodemográficas en pacientes que viven en altitudes bajas y altas, diagnosticados con vólvulo de sigmoides y sometidos a intervención quirúrgica entre 2010 y 2022. Métodos: Se realizó un estudio de cohorte retrospectivo que incluyó pacientes sometidos a cirugía por vólvulo de sigmoides entre 2010 y 2022. La población se dividió según la altitud sobre el nivel del mar en la que residían. Se emplearon estadísticas descriptivas y análisis univariado para comparar ambas cohortes. Resultados: El 52,1 % de los pacientes que vivían por debajo de los 2500 metros sobre el nivel del mar (msnm) tenían más de 60 años (55,0 % vs. 52,1 %; p=0,004). La población que vivía por encima de los 2500 msnm presentó un mayor porcentaje de tejido necrótico (70,0 % vs. 31,0 %, p<0,001). No se observaron diferencias en los tipos de cirugía (resección primaria con anastomosis vs. procedimiento de Hartmann; 46,7 % vs. 60,6 %, p=0,112). Los pacientes de altitudes bajas tuvieron más complicaciones totales (18,3 % vs. 36,6 %, p=0,021) y de heridas (10,0 % vs. 26,8 %, p=0,015), a pesar de la mayor frecuencia de tejido necrótico en el grupo de mayor altitud (70,0 % vs. 31,0 %, p<0,001). La mayoría de los pacientes de ambas zonas lograron recuperación completa tras la cirugía (88,3 % vs. 100 %, p=0,003) y fueron dados de alta tras un promedio de 9 días (10,16 vs. 4,85, p=0,160). Conclusiones: Los pacientes con diagnóstico de vólvulo de sigmoides que vivían a más de 2500 metros eran mayores, residían en áreas rurales, presentaban mayor progresión de la enfermedad debido a tejido necrótico, y tenían una menor tasa de complicaciones generales y de heridas...
- Open Access
- 27 June 2024
- Published by Cuerpo Médico del Hospital Nacional Edgardo Rebagliati Martins in Revista Médica Rebagliati
- Vol. 4 (1) , 24-30
Factores asociados a síndrome coronario agudo en pacientes hospitalizados por COVID-19
Objective: To evaluate the factors associated with acute coronary syndrome (ACS) in patients hospitalized for COVID-19 at the Hospital Nacional Edgardo Rebagliati Martins (Lima, Peru). Materials and methods: A case-control study was conducted, recruiting two groups of patients based on the diagnosis of ACS during their hospitalization for COVID-19 between March 2020 and March 2021 (60 cases and 120 controls). Sociodemographic and clinical factors and data related to the diagnosis and hospitalization for COVID-19 were measured. Associations and thestrength of association (odds ratio, OR) were assessed using nonparametric bivariate analyzes and logistic regression. Results: In the bivariate analysis, it was observed that a history of arterial hypertension, heart failure, coronary disease, cancer, and previous acute coronary syndrome were found to be associated with presenting SICA (systemic inflammatory response syndromein children and adolescents). Likewise, during hospitalization, it was observed that cough,headache, systolic and diastolic blood pressure, sensory disorder, affected lobes, troponins, C-reactive protein, neutrophils, lymphocytes, and creatinine were associated with the event. In the multivariate analysis, only the aforementioned pathological antecedents were maintained. Conclusion: Although hospitalization for COVID-19 could be related to a higher frequency of SICA, the factors observed during hospitalization for COVID-19 would not significantly affect the occurrence of SICA.
- 27 June 2024
- Published by Cuerpo Médico del Hospital Nacional Edgardo Rebagliati Martins in Revista Médica Rebagliati
- Vol. 4 (1) , 24-30
Open AccessFactores asociados a síndrome coronario agudo en pacientes hospitalizados por COVID-19
Objective: To evaluate the factors associated with acute coronary syndrome (ACS) in patients hospitalized for COVID-19 at the Hospital Nacional Edgardo Rebagliati Martins (Lima, Peru). Materials and methods: A case-control study was conducted, recruiting two groups of patients based on the diagnosis of ACS during their hospitalization for COVID-19 between March 2020 and March 2021 (60 cases and 120 controls). Sociodemographic and clinical factors and data related to the diagnosis and hospitalization for COVID-19 were measured. Associations and thestrength of association (odds ratio, OR) were assessed using nonparametric bivariate analyzes and logistic regression. Results: In the bivariate analysis, it was observed that a history of arterial hypertension, heart failure, coronary disease, cancer, and previous acute coronary syndrome were found to be associated with presenting SICA (systemic inflammatory response syndromein children and adolescents). Likewise, during hospitalization, it was observed that cough,headache, systolic and diastolic blood pressure, sensory disorder, affected lobes, troponins, C-reactive protein, neutrophils, lymphocytes, and creatinine were associated with the event. In the multivariate analysis, only the aforementioned pathological antecedents were maintained. Conclusion: Although hospitalization for COVID-19 could be related to a higher frequency of SICA, the factors observed during hospitalization for COVID-19 would not significantly affect the occurrence of SICA.
- Open Access
- 1 January 2024
- Published by XMLink in Clinical and Experimental Vaccine Research
- Vol. 13 (1) , 42-53
Acute abdomen following COVID-19 vaccination: a systematic review
Conduct a systematic review of case reports and case series regarding the development of acute abdomen following coronavirus disease 2019 (COVID-19) vaccination, to describe the possible association and the clinical and demographic characteristics in detail. This study included case report studies and case series that focused on the development of acute abdomen following COVID-19 vaccination. Systematic review studies, literature, letters to the editor, brief comments, and so forth were excluded. PubMed, Scopus, EMBASE, and Web of Science databases were searched until June 15, 2023. The Joanna Briggs Institute tool was used to assess the risk of bias and the quality of the study. Descriptive data were presented as frequency, median, mean, and standard deviation. Seventeen clinical case studies were identified, evaluating 17 patients with acute abdomen associated with COVID-19 vaccination, which included acute appendicitis (n=3), acute pancreatitis (n=9), diverticulitis (n=1), cholecystitis (n=2), and colitis (n=2). The COVID-19 vaccine most commonly linked to acute abdomen was Pfizer-BioNTech (messenger RNA), accounting for 64.71% of cases. Acute abdomen predominantly occurred after the first vaccine dose (52.94%). All patients responded objectively to medical (88.34%) and surgical (11.76%) treatment and were discharged within a few weeks. No cases of death were reported. Acute abdomen is a rare complication of great interest in the medical and surgical practice of COVID-19 vaccination. Our study is based on a small sample of patients; therefore, it is recommended to conduct future observational studies to fully elucidate the underlying mechanisms of this association.
- 1 January 2024
- Published by XMLink in Clinical and Experimental Vaccine Research
- Vol. 13 (1) , 42-53
Open AccessAcute abdomen following COVID-19 vaccination: a systematic review
Conduct a systematic review of case reports and case series regarding the development of acute abdomen following coronavirus disease 2019 (COVID-19) vaccination, to describe the possible association and the clinical and demographic characteristics in detail. This study included case report studies and case series that focused on the development of acute abdomen following COVID-19 vaccination. Systematic review studies, literature, letters to the editor, brief comments, and so forth were excluded. PubMed, Scopus, EMBASE, and Web of Science databases were searched until June 15, 2023. The Joanna Briggs Institute tool was used to assess the risk of bias and the quality of the study. Descriptive data were presented as frequency, median, mean, and standard deviation. Seventeen clinical case studies were identified, evaluating 17 patients with acute abdomen associated with COVID-19 vaccination, which included acute appendicitis (n=3), acute pancreatitis (n=9), diverticulitis (n=1), cholecystitis (n=2), and colitis (n=2). The COVID-19 vaccine most commonly linked to acute abdomen was Pfizer-BioNTech (messenger RNA), accounting for 64.71% of cases. Acute abdomen predominantly occurred after the first vaccine dose (52.94%). All patients responded objectively to medical (88.34%) and surgical (11.76%) treatment and were discharged within a few weeks. No cases of death were reported. Acute abdomen is a rare complication of great interest in the medical and surgical practice of COVID-19 vaccination. Our study is based on a small sample of patients; therefore, it is recommended to conduct future observational studies to fully elucidate the underlying mechanisms of this association.
- Open Access
- 1 March 2023
- Published by Modestum Ltd in Electronic Journal of General Medicine
- Vol. 20 (2) , em443
HIV therapy adherence and outcomes in Peruvian military personnel over a 30-year period
Objectives: We aimed to describe the sociodemographic, clinical, and therapeutic characteristics of Peruvian military personnel diagnosed with HIV. Furthermore, we determined the frequency of highly active antiretroviral therapy (HAART) adherence, the complications and mortality. Methods: We retrospectively reviewed the medical records of patients diagnosed with HIV, confirmed by Western blot at a single institution from 1989-2020. Descriptive analyses were performed for all the variables using mean and standard deviation (SD) in the case of quantitative variables, and frequency and percentage for qualitative variables. Results: Of the 161 patients included, 95.7% were males and the mean age was 39.59 years (SD= 16.45 years). Most had college or higher education (67.7%) and were on active duty at diagnosis (77%). 35.4% had AIDS at diagnosis; 28.6% opportunistic infections; and 8.1% tuberculosis. The median follow-up was five years. 94.4% of the patients received HAART as the principal treatment; of these, 88.8% was adherent to treatment, and death was reported in 6.8%. There were no factors associated with adherence. Conclusions: Although the sociodemographic characteristics of Peruvian military personnel are similar to those of other countries, our findings suggest that Peruvian military personnel present higher adherence to HAART compared to previous studies in other military populations from South American countries. Further studies are recommended to assess specific factors attributed to these successful outcomes in the military personnel that can be applied in other hospitals.
- 1 March 2023
- Published by Modestum Ltd in Electronic Journal of General Medicine
- Vol. 20 (2) , em443
Open AccessHIV therapy adherence and outcomes in Peruvian military personnel over a 30-year period
Objectives: We aimed to describe the sociodemographic, clinical, and therapeutic characteristics of Peruvian military personnel diagnosed with HIV. Furthermore, we determined the frequency of highly active antiretroviral therapy (HAART) adherence, the complications and mortality. Methods: We retrospectively reviewed the medical records of patients diagnosed with HIV, confirmed by Western blot at a single institution from 1989-2020. Descriptive analyses were performed for all the variables using mean and standard deviation (SD) in the case of quantitative variables, and frequency and percentage for qualitative variables. Results: Of the 161 patients included, 95.7% were males and the mean age was 39.59 years (SD= 16.45 years). Most had college or higher education (67.7%) and were on active duty at diagnosis (77%). 35.4% had AIDS at diagnosis; 28.6% opportunistic infections; and 8.1% tuberculosis. The median follow-up was five years. 94.4% of the patients received HAART as the principal treatment; of these, 88.8% was adherent to treatment, and death was reported in 6.8%. There were no factors associated with adherence. Conclusions: Although the sociodemographic characteristics of Peruvian military personnel are similar to those of other countries, our findings suggest that Peruvian military personnel present higher adherence to HAART compared to previous studies in other military populations from South American countries. Further studies are recommended to assess specific factors attributed to these successful outcomes in the military personnel that can be applied in other hospitals.